Serum Interleukin-33 Levels in Patients with Gastric Cancer

被引:0
作者
Pinghu Sun
Qiwen Ben
Shuiping Tu
Wenjie Dong
Xiaoguang Qi
Yunlin Wu
机构
[1] Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Department of Gastroenterology
[2] Changhai Hospital of Second Military Medical University,Department of Gastroenterology
来源
Digestive Diseases and Sciences | 2011年 / 56卷
关键词
Interleukin-33; Gastric cancer; ELISA; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3596 / 3601
页数:5
相关论文
共 110 条
[1]  
Pisani P(1993)Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden Int J Cancer 55 891-903
[2]  
Parkin DM(2002)The epidemiology of gastric cancer Semin Radiat Oncol 12 111-127
[3]  
Ferlay J(2009)Serum interleukin-6 and -10 levels in patients with gastric cancer Gastric Cancer 12 95-100
[4]  
Terry MB(1992)Interleukin-6 activity in urine and serum in patients with bladder carcinoma J Urol 148 791-794
[5]  
Gaudet MM(1996)Increased interleukin-10 serum levels in patients with solid tumors Cancer Lett 104 1-5
[6]  
Gammon MD(2009)Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44 Carcinogenesis 30 1987-1996
[7]  
Ikeguchi M(2006)Diagnostic role of serum interleukin-18 in gastric cancer patients World J Gastroenterol 12 4473-4477
[8]  
Hatada T(2009)IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers J Gastroenterol Hepatol 24 1119-1122
[9]  
Yamamoto M(2007)IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc Natl Acad Sci USA 104 282-287
[10]  
Seguchi T(2005)IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 479-490